Filtros : "DOENÇA DE CHAGAS" "Emirados Árabes Unidos" Removido: "1979" Limpar

Filtros



Refine with date range


  • Source: Current Medicinal Chemistry. Unidade: FCF

    Subjects: TRYPANOSOMA CRUZI, DOENÇA DE CHAGAS, DESENVOLVIMENTO DE PRODUTOS, PRODUTOS NOVOS, FÁRMACOS

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      PRATES, João Lucas Bruno et al. Discovery of novel inhibitors of Cruzain cysteine protease of Trypanosoma cruzi. Current Medicinal Chemistry, v. 31, n. 16, p. 2285-2308, 2024Tradução . . Disponível em: https://dx.doi.org/10.2174/0109298673254864230921090. Acesso em: 12 nov. 2024.
    • APA

      Prates, J. L. B., Lopes, J. R., Chin, C. M., Ferreira, E. I., Santos, J. L. dos, & Scarim, C. B. (2024). Discovery of novel inhibitors of Cruzain cysteine protease of Trypanosoma cruzi. Current Medicinal Chemistry, 31( 16), 2285-2308. doi:10.2174/0109298673254864230921090
    • NLM

      Prates JLB, Lopes JR, Chin CM, Ferreira EI, Santos JL dos, Scarim CB. Discovery of novel inhibitors of Cruzain cysteine protease of Trypanosoma cruzi [Internet]. Current Medicinal Chemistry. 2024 ; 31( 16): 2285-2308.[citado 2024 nov. 12 ] Available from: https://dx.doi.org/10.2174/0109298673254864230921090
    • Vancouver

      Prates JLB, Lopes JR, Chin CM, Ferreira EI, Santos JL dos, Scarim CB. Discovery of novel inhibitors of Cruzain cysteine protease of Trypanosoma cruzi [Internet]. Current Medicinal Chemistry. 2024 ; 31( 16): 2285-2308.[citado 2024 nov. 12 ] Available from: https://dx.doi.org/10.2174/0109298673254864230921090
  • Source: Current Topics in Medicinal Chemistry. Unidade: EACH

    Assunto: DOENÇA DE CHAGAS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BARBOSA, Henrique et al. The potential of secondary metabolites from plants as drugs or leads against trypanosoma cruzi-An Update from 2012 to 2021. Current Topics in Medicinal Chemistry, v. 23, n. Ja 2023, p. 159-213, 2023Tradução . . Disponível em: https://doi.org/10.2174/1568026623666221212111514. Acesso em: 12 nov. 2024.
    • APA

      Barbosa, H., Thevenard, F., Reimão, J. Q., Tempone, A. G. T., Honorio, K. M., & Lago, J. H. G. (2023). The potential of secondary metabolites from plants as drugs or leads against trypanosoma cruzi-An Update from 2012 to 2021. Current Topics in Medicinal Chemistry, 23( Ja 2023), 159-213. doi:10.2174/1568026623666221212111514
    • NLM

      Barbosa H, Thevenard F, Reimão JQ, Tempone AGT, Honorio KM, Lago JHG. The potential of secondary metabolites from plants as drugs or leads against trypanosoma cruzi-An Update from 2012 to 2021 [Internet]. Current Topics in Medicinal Chemistry. 2023 ; 23( Ja 2023): 159-213.[citado 2024 nov. 12 ] Available from: https://doi.org/10.2174/1568026623666221212111514
    • Vancouver

      Barbosa H, Thevenard F, Reimão JQ, Tempone AGT, Honorio KM, Lago JHG. The potential of secondary metabolites from plants as drugs or leads against trypanosoma cruzi-An Update from 2012 to 2021 [Internet]. Current Topics in Medicinal Chemistry. 2023 ; 23( Ja 2023): 159-213.[citado 2024 nov. 12 ] Available from: https://doi.org/10.2174/1568026623666221212111514
  • Source: Current Organic Chemistry. Unidade: FCF

    Subjects: DOENÇA DE CHAGAS, SÍNTESE ORGÂNICA

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MORAIS, Pedro Alves Bezerra e TROSSINI, Gustavo Henrique Goulart. Cruzain inhibitors: state-of-art of novel synthetic strategies. Current Organic Chemistry, v. 27, n. 4, p. 243-247, 2023Tradução . . Disponível em: https://doi.org/10.2174/1385272827666230418100932. Acesso em: 12 nov. 2024.
    • APA

      Morais, P. A. B., & Trossini, G. H. G. (2023). Cruzain inhibitors: state-of-art of novel synthetic strategies. Current Organic Chemistry, 27( 4), 243-247. doi:10.2174/1385272827666230418100932
    • NLM

      Morais PAB, Trossini GHG. Cruzain inhibitors: state-of-art of novel synthetic strategies [Internet]. Current Organic Chemistry. 2023 ; 27( 4): 243-247.[citado 2024 nov. 12 ] Available from: https://doi.org/10.2174/1385272827666230418100932
    • Vancouver

      Morais PAB, Trossini GHG. Cruzain inhibitors: state-of-art of novel synthetic strategies [Internet]. Current Organic Chemistry. 2023 ; 27( 4): 243-247.[citado 2024 nov. 12 ] Available from: https://doi.org/10.2174/1385272827666230418100932
  • Source: Current Topics in Medicinal Chemistry. Unidade: IFSC

    Subjects: DOENÇAS NEGLIGENCIADAS, PLANEJAMENTO DE FÁRMACOS, DOENÇA DE CHAGAS, CORONAVIRUS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      FERREIRA, Leonardo Luiz Gomes e ANDRICOPULO, Adriano Defini. World chagas disease day and the new road map for neglected tropical diseases. [Editorial]. Current Topics in Medicinal Chemistry. Sharjah: Instituto de Física de São Carlos, Universidade de São Paulo. Disponível em: https://doi.org/10.2174/156802662017200624115305. Acesso em: 12 nov. 2024. , 2020
    • APA

      Ferreira, L. L. G., & Andricopulo, A. D. (2020). World chagas disease day and the new road map for neglected tropical diseases. [Editorial]. Current Topics in Medicinal Chemistry. Sharjah: Instituto de Física de São Carlos, Universidade de São Paulo. doi:10.2174/156802662017200624115305
    • NLM

      Ferreira LLG, Andricopulo AD. World chagas disease day and the new road map for neglected tropical diseases. [Editorial] [Internet]. Current Topics in Medicinal Chemistry. 2020 ; 20( 17): 1518-1520.[citado 2024 nov. 12 ] Available from: https://doi.org/10.2174/156802662017200624115305
    • Vancouver

      Ferreira LLG, Andricopulo AD. World chagas disease day and the new road map for neglected tropical diseases. [Editorial] [Internet]. Current Topics in Medicinal Chemistry. 2020 ; 20( 17): 1518-1520.[citado 2024 nov. 12 ] Available from: https://doi.org/10.2174/156802662017200624115305
  • Source: Current Medicinal Chemistry. Unidade: FCFRP

    Subjects: LEISHMANIOSE CUTÂNEA, DOENÇAS NEGLIGENCIADAS, DOENÇA DE CHAGAS, MALÁRIA, TUBERCULOSE

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MANTOANI, Susimaire Pedersoli et al. Potential Triazole-based molecules for the treatment of neglected diseases. Current Medicinal Chemistry, v. 26, n. 23, p. 4403-4434, 2019Tradução . . Disponível em: https://doi.org/10.2174/0929867324666170727103901. Acesso em: 12 nov. 2024.
    • APA

      Mantoani, S. P., Andrade, P. de, Chierrito, T. P. C., Figueredo, A. da S., & Carvalho, I. (2019). Potential Triazole-based molecules for the treatment of neglected diseases. Current Medicinal Chemistry, 26( 23), 4403-4434. doi:10.2174/0929867324666170727103901
    • NLM

      Mantoani SP, Andrade P de, Chierrito TPC, Figueredo A da S, Carvalho I. Potential Triazole-based molecules for the treatment of neglected diseases [Internet]. Current Medicinal Chemistry. 2019 ; 26( 23): 4403-4434.[citado 2024 nov. 12 ] Available from: https://doi.org/10.2174/0929867324666170727103901
    • Vancouver

      Mantoani SP, Andrade P de, Chierrito TPC, Figueredo A da S, Carvalho I. Potential Triazole-based molecules for the treatment of neglected diseases [Internet]. Current Medicinal Chemistry. 2019 ; 26( 23): 4403-4434.[citado 2024 nov. 12 ] Available from: https://doi.org/10.2174/0929867324666170727103901
  • Source: Mini Reviews in Medicinal Chemistry. Unidade: FCF

    Subjects: DOENÇA DE CHAGAS, LEISHMANIA, MALÁRIA, TUBERCULOSE, DOENÇAS NEGLIGENCIADAS

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      GIAROLLA, Jeanine e FERREIRA, Elizabeth Igne. Drug design for neglected disease in Brazil. Mini Reviews in Medicinal Chemistry, v. 15, n. 3, p. 220-242, 2015Tradução . . Acesso em: 12 nov. 2024.
    • APA

      Giarolla, J., & Ferreira, E. I. (2015). Drug design for neglected disease in Brazil. Mini Reviews in Medicinal Chemistry, 15( 3), 220-242.
    • NLM

      Giarolla J, Ferreira EI. Drug design for neglected disease in Brazil. Mini Reviews in Medicinal Chemistry. 2015 ; 15( 3): 220-242.[citado 2024 nov. 12 ]
    • Vancouver

      Giarolla J, Ferreira EI. Drug design for neglected disease in Brazil. Mini Reviews in Medicinal Chemistry. 2015 ; 15( 3): 220-242.[citado 2024 nov. 12 ]
  • Source: Letters in Drug Design & Discovery. Unidade: FCF

    Subjects: MODELAGEM MOLECULAR, DOENÇA DE CHAGAS

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      VITAL, Drielli Gomes e ARRIBAS, Marco e TROSSINI, Gustavo Henrique Goulart. Molecular modeling and docking application to evaluate cruzain inhibitory activity by chalcones and hydrazides. Letters in Drug Design & Discovery, v. 11, n. 3, p. 249-255, 2014Tradução . . Acesso em: 12 nov. 2024.
    • APA

      Vital, D. G., Arribas, M., & Trossini, G. H. G. (2014). Molecular modeling and docking application to evaluate cruzain inhibitory activity by chalcones and hydrazides. Letters in Drug Design & Discovery, 11( 3), 249-255.
    • NLM

      Vital DG, Arribas M, Trossini GHG. Molecular modeling and docking application to evaluate cruzain inhibitory activity by chalcones and hydrazides. Letters in Drug Design & Discovery. 2014 ; 11( 3): 249-255.[citado 2024 nov. 12 ]
    • Vancouver

      Vital DG, Arribas M, Trossini GHG. Molecular modeling and docking application to evaluate cruzain inhibitory activity by chalcones and hydrazides. Letters in Drug Design & Discovery. 2014 ; 11( 3): 249-255.[citado 2024 nov. 12 ]
  • Source: Letters in Drug Design & Discovery. Unidade: FCF

    Subjects: DOENÇA DE CHAGAS, TRYPANOSOMA CRUZI, PROTEINASES, MODELAGEM MOLECULAR

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      TROSSINI, Gustavo Henrique Goulart et al. Molecular modeling suggests cruzain specificity for peptide primaquine prodrugs. Letters in Drug Design & Discovery, v. 7, n. 7, p. 528-533, 2010Tradução . . Disponível em: https://doi.org/10.2174/157018010791526287. Acesso em: 12 nov. 2024.
    • APA

      Trossini, G. H. G., Chin, C. M., Menezes, C. M. de S., & Ferreira, E. I. (2010). Molecular modeling suggests cruzain specificity for peptide primaquine prodrugs. Letters in Drug Design & Discovery, 7( 7), 528-533. doi:10.2174/157018010791526287
    • NLM

      Trossini GHG, Chin CM, Menezes CM de S, Ferreira EI. Molecular modeling suggests cruzain specificity for peptide primaquine prodrugs [Internet]. Letters in Drug Design & Discovery. 2010 ; 7( 7): 528-533.[citado 2024 nov. 12 ] Available from: https://doi.org/10.2174/157018010791526287
    • Vancouver

      Trossini GHG, Chin CM, Menezes CM de S, Ferreira EI. Molecular modeling suggests cruzain specificity for peptide primaquine prodrugs [Internet]. Letters in Drug Design & Discovery. 2010 ; 7( 7): 528-533.[citado 2024 nov. 12 ] Available from: https://doi.org/10.2174/157018010791526287

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024